Array
(
[id] => 630133
[patent_doc_number] => 07132108
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-07
[patent_title] => 'Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria'
[patent_app_type] => utility
[patent_app_number] => 09/958210
[patent_app_country] => US
[patent_app_date] => 2000-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 3851
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/132/07132108.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958210
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958210 | Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria | Feb 7, 2000 | Issued |
Array
(
[id] => 101886
[patent_doc_number] => 07722887
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-05-25
[patent_title] => 'Detoxified mutants of escherichia coli heat-labile enterotoxin'
[patent_app_type] => utility
[patent_app_number] => 10/088202
[patent_app_country] => US
[patent_app_date] => 1999-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7208
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/722/07722887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10088202
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/088202 | Detoxified mutants of escherichia coli heat-labile enterotoxin | Sep 14, 1999 | Issued |
Array
(
[id] => 303307
[patent_doc_number] => 07534443
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-05-19
[patent_title] => 'Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 09/743750
[patent_app_country] => US
[patent_app_date] => 1999-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 11079
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534443.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743750
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743750 | Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient | Jul 15, 1999 | Issued |
Array
(
[id] => 7612928
[patent_doc_number] => 06902906
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines'
[patent_app_type] => utility
[patent_app_number] => 09/646925
[patent_app_country] => US
[patent_app_date] => 1999-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8350
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/902/06902906.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646925
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646925 | Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines | Mar 24, 1999 | Issued |